News

Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a proprietary drug-delivery technology to improve patient access, safety, and convenience, today announced the closing of a bridge financing with a syndicate of investors. Following the closing, the investors exercised a purchase option to acquire all of the outstanding common stock of the Company not already held by the investors to take the Company private. The financing and option exercise follows a robust effort by the Company, led by a Special Committee of the Company's Board of Directors, to explore strategic alternatives to maximize shareholder value.

01/04/2024

Comera Life Sciences Announces Process Exploring Strategic Alternatives

WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value.

12/06/2023

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Comera Life Sciences Holdings, Inc. (CMRA) a buy, sell, or hold?

Comera Life Sciences Holdings, Inc. (CMRA) can hold. Click on Rating Page for detail.

What is Comera Life Sciences Holdings, Inc.'s stock price?

The price of Comera Life Sciences Holdings, Inc. (CMRA) is 0.0001 and it was updated on 2025-05-08 07:01:11.

Is Comera Life Sciences Holdings, Inc. (CMRA) overvalued or undervalued?

Currently Comera Life Sciences Holdings, Inc. (CMRA) is in undervalued.

News

From:

To:

News
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of directors. Mon, Nov. 13, 2023
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights – Final stage of technical evaluation near completion in Comera's research collaboration with Regeneron, a leading U.S. biotechnology company – Thu, Nov. 09, 2023
Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today will present research demonstrating Comera's SQore™ platform capabilities in the development of subcutaneous monoclonal antibody formulations at the PODD: Partnerships in Drug Delivery conference in Boston, Mass. Mon, Oct. 16, 2023
These Are the ONLY 7 Penny Stocks to Consider in August 2023 Some of the most promising penny stocks can have multi-bagger potential over the long haul. After all, the combination of low prices, strong catalysts, and potentially high returns can be appealing. Sat, Aug. 26, 2023
Comera Life Sciences Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies Wed, Aug. 16, 2023

SEC Filings

SEC Filings
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 02/28/2024
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 02/28/2024
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 02/28/2024
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 02/28/2024
Comera Life Sciences Holdings, Inc. (CMRA) - S-8 POS SEC Filings 02/26/2024
Comera Life Sciences Holdings, Inc. (CMRA) - POS AM SEC Filings 02/26/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 02/26/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 25-NSE SEC Filings 02/15/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 02/02/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 02/02/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 01/30/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 01/30/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 01/11/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 01/11/2024
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D SEC Filings 01/08/2024
Comera Life Sciences Holdings, Inc. (CMRA) - D SEC Filings 01/08/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 01/08/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 01/05/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 01/05/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 01/04/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 01/04/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 01/03/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 01/03/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 01/03/2024
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 12/29/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 12/29/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 12/06/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 12/06/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 11/28/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 11/17/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 11/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 11/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 11/14/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 11/13/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 11/13/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 11/09/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 11/09/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 10-Q - Quarterly Report SEC Filings 11/09/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 11/03/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 11/03/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 10/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 10/11/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 10/06/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 10/02/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 09/28/2023
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 09/14/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 09/13/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 09/13/2023
Comera Life Sciences Holdings, Inc. (CMRA) - S-8 SEC Filings 09/12/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 09/12/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 09/11/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D/A SEC Filings 09/08/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G/A SEC Filings 09/06/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 09/01/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 09/01/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 09/01/2023
Comera Life Sciences Holdings, Inc. (CMRA) - S-3 SEC Filings 08/29/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D/A SEC Filings 08/28/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 08/25/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G SEC Filings 08/24/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G SEC Filings 08/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 08/15/2023
Comera Life Sciences Holdings, Inc. (CMRA) - DEF 14A SEC Filings 08/11/2023
Comera Life Sciences Holdings, Inc. (CMRA) - ARS SEC Filings 08/11/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G SEC Filings 08/10/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 08/10/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 08/10/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 10-Q - Quarterly Report SEC Filings 08/10/2023
Comera Life Sciences Holdings, Inc. (CMRA) - D SEC Filings 08/07/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D/A SEC Filings 08/04/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 08/02/2023
Comera Life Sciences Holdings, Inc. (CMRA) - PRE 14A SEC Filings 08/01/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 08/01/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 05/19/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 05/19/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 05/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 05/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 05/12/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 05/12/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 10-Q - Quarterly Report SEC Filings 05/12/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 05/05/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 05/05/2023
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 03/31/2023
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 03/31/2023
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 03/31/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 03/31/2023
Comera Life Sciences Holdings, Inc. (CMRA) - POS AM SEC Filings 03/27/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 03/24/2023
Comera Life Sciences Holdings, Inc. (CMRA) - S-8 SEC Filings 03/17/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 10-K - Current report SEC Filings 03/17/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 03/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 02/21/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 02/21/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 02/16/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 5 SEC Filings 02/14/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4/A SEC Filings 02/14/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 3/A SEC Filings 02/14/2023
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 02/13/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 02/10/2023
Comera Life Sciences Holdings, Inc. (CMRA) - S-1/A SEC Filings 02/08/2023
Comera Life Sciences Holdings, Inc. (CMRA) - S-1 SEC Filings 02/03/2023
Comera Life Sciences Holdings, Inc. (CMRA) - D SEC Filings 01/12/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G SEC Filings 01/10/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D/A SEC Filings 01/09/2023
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D/A SEC Filings 01/06/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 01/06/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 01/06/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 01/05/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 01/04/2023
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 11/23/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 11/23/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 11/14/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 11/10/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 11/09/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 11/09/2022
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D SEC Filings 10/28/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 10/28/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 10/24/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 10/18/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 10/14/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 09/30/2022
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 09/16/2022
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 09/16/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 09/15/2022
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13D SEC Filings 09/13/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-1 SEC Filings 09/06/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 09/06/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 09/06/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-1 SEC Filings 09/02/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 09/02/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 09/02/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 08/31/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 08/31/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 08/15/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 08/15/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 10-Q - Quarterly Report SEC Filings 08/15/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-8 SEC Filings 08/12/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 08/11/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 07/29/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 06/28/2022
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 06/27/2022
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 06/27/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-1/A SEC Filings 06/23/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-1/A SEC Filings 06/22/2022
Comera Life Sciences Holdings, Inc. (CMRA) - CORRESP SEC Filings 06/22/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 06/17/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 4 SEC Filings 06/17/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 06/17/2022
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G/A SEC Filings 06/16/2022
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G SEC Filings 06/03/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-1/A SEC Filings 06/03/2022
Comera Life Sciences Holdings, Inc. (CMRA) - CORRESP SEC Filings 06/02/2022
Comera Life Sciences Holdings, Inc. (CMRA) - SC 13G SEC Filings 05/31/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 05/31/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-K - Current report SEC Filings 05/25/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 3 SEC Filings 05/20/2022
Comera Life Sciences Holdings, Inc. (CMRA) - CERT SEC Filings 05/19/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 8-A12B SEC Filings 05/19/2022
Comera Life Sciences Holdings, Inc. (CMRA) - UPLOAD SEC Filings 05/16/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 425 SEC Filings 05/10/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 425 SEC Filings 05/09/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-1 SEC Filings 05/05/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-1 SEC Filings 05/04/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 425 SEC Filings 04/27/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 425 SEC Filings 04/19/2022
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 04/18/2022
Comera Life Sciences Holdings, Inc. (CMRA) - EFFECT SEC Filings 04/18/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 425 SEC Filings 04/18/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 424B3 SEC Filings 04/15/2022
Comera Life Sciences Holdings, Inc. (CMRA) - CORRESP SEC Filings 04/13/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-4/A SEC Filings 04/11/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-4/A SEC Filings 04/06/2022
Comera Life Sciences Holdings, Inc. (CMRA) - CORRESP SEC Filings 04/06/2022
Comera Life Sciences Holdings, Inc. (CMRA) - UPLOAD SEC Filings 04/01/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-4/A SEC Filings 03/25/2022
Comera Life Sciences Holdings, Inc. (CMRA) - CORRESP SEC Filings 03/25/2022
Comera Life Sciences Holdings, Inc. (CMRA) - UPLOAD SEC Filings 03/22/2022
Comera Life Sciences Holdings, Inc. (CMRA) - DEL AM SEC Filings 03/10/2022
Comera Life Sciences Holdings, Inc. (CMRA) - S-4 SEC Filings 03/09/2022
Comera Life Sciences Holdings, Inc. (CMRA) - CORRESP SEC Filings 03/08/2022
Comera Life Sciences Holdings, Inc. (CMRA) - UPLOAD SEC Filings 03/02/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 425 SEC Filings 02/08/2022
Comera Life Sciences Holdings, Inc. (CMRA) - 425 SEC Filings 02/04/2022
Comera Life Sciences Holdings, Inc. (CMRA) - DRSLTR SEC Filings 02/03/2022
Comera Life Sciences Holdings, Inc. (CMRA) - DRS SEC Filings 02/03/2022

Press Releases

StockPrice Release
Comera life sciences announces bridge financing and exercise of take private option 01/04/2024
Comera life sciences announces process exploring strategic alternatives 12/06/2023
Comera life sciences appoints dorothy clarke to board of directors 11/13/2023
Comera life sciences reports financial results for third quarter 2023 and recent business highlights 11/09/2023
Comera life sciences presents sqore™ platform technology data at podd: partnerships in drug delivery conference 10/16/2023
Comera life sciences announces publication of study reinforcing caffeine's viscosity reducing capabilities 08/16/2023
Comera life sciences reports financial results for second quarter 2023 and recent business highlights 08/10/2023
Comera life sciences significantly expands intellectual property portfolio strengthening the proprietary sqore™ platform 08/08/2023
Comera life sciences announces collaboration with quality chemical laboratories to secure proprietary supply of sqore excipients 07/20/2023
Comera life sciences reports financial results for first quarter 2023 and recent business highlights 05/11/2023
Comera life sciences announces expansion of patent portfolio underlying core excipient technology 04/03/2023
Comera life sciences reports financial results for fourth quarter and full year 2022 and recent business highlights 03/16/2023
Comera life sciences to present at 22nd annual peptalk conference 01/12/2023
Comera life sciences closes $3.6 million private placement priced at-the-market under nasdaq rules 01/04/2023
Comera life sciences to participate in the benchmark company's upcoming discovery one-on-one investor conference 11/17/2022
Comera life sciences announces favorable preclinical results of lead sqore excipient in sequrus-2 study 10/18/2022
Comera life sciences expands woburn operations 10/04/2022
Comera life sciences announces up to $15 million purchase agreement with arena business solutions 08/31/2022
Comera life sciences provides business highlights and reports financial results for the second quarter 2022 08/10/2022

More Headlines

News
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights – Advanced to final stage of technical evaluation in Comera's research collaboration with Regeneron, a leading U.S. biotechnology company – 08/10/2023
Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced a significant expansion of its SQore™ patent portfolio with the issuance of four new patents and two new notices of allowance. The six new patents, three issued in the United States and three covering Canada, Korea and India expand the number of proprietary viscosity reducing excipients in Comera's SQore platform and significantly broaden claims covered by previously issued patents. 08/08/2023
Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients – Ownership of proprietary sourcing for U.S.-manufactured lead SQore excipients allows for full control over supply chain and greater flexibility to support product development needs – 07/20/2023
Comera Life Sciences to Present at 22nd Annual PepTalk Conference WOBURN, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced it will present at the 22nd Annual PepTalk Conference, in San Diego on Wednesday, Jan. 18, 2023 at 5:15 p.m. PT. The conference will run from Monday, Jan. 16 through Friday, Jan. 20. 01/12/2023
Comera Life Sciences to Participate in the Benchmark Company's Upcoming Discovery One-on-One Investor Conference WOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced it will be participating in the Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York. 11/17/2022
3 Hot Penny Stocks To Buy According To Insiders In September Penny stocks to buy? That's what these insiders think. 09/15/2022
Top Penny Stocks to Watch After the Market Crash Here's what you need to know about buying penny stocks today The post Top Penny Stocks to Watch After the Market Crash appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 09/14/2022
Insiders Are Buying Up Comera Life Sciences (CMRA) Stock. Here's Why. Shares of Comera Life Sciences (NASDAQ: CMRA ) are up by over 30% following a flurry of insider purchases. As the name suggests, Comera is a life sciences company that seeks to improve traditional intravenous injections through its SQore platform. 09/13/2022
Best Penny Stocks To Buy As Recession Begins? 5 Biotech Stocks To Watch Biotech penny stocks to watch this week. The post Best Penny Stocks To Buy As Recession Begins? 07/28/2022
Best Penny Stocks To Buy? 4 To Watch After PGY Stock Explodes 790% Penny stocks are some of the most volatile investments in the stock 07/26/2022
3 Top Stocks To Watch Before Next Week Penny stocks to watch right now. The post 3 Top Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 06/17/2022

Unlock

CMRA Ratings Summary

CMRA Quant Ranking